Preservation of Renal Function and Cardiovascular Risk Factors (original) (raw)

One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus

A. Dębska-Ślizień

Transplantation proceedings

View PDFchevron_right

Histopathological findings in well-functioning, long-term renal allografts

Eero Taskinen

Kidney International, 1992

View PDFchevron_right

Causes of late transplant failure in cyclosporine-treated kidney allograft recipients

E. Favi

Clinical and Experimental Nephrology, 2019

View PDFchevron_right

Chronic renal allograft dysfunction: risk factors, immunology and prevention

Mostapha Habib Allah

Arab journal of nephrology and transplantation, 2013

View PDFchevron_right

Causes of Renal Allograft Loss: Progress in the 1980s, Challenges for the 1990s

arthur matas

Annals of Surgery, 1991

View PDFchevron_right

Early prediction of renal allograft loss beyond one year

David Nicol

Transplant International, 1993

View PDFchevron_right

A Comparison of Allograft Survival Between Cyclosporine and Tacrolimus Based Immunosuppressive Therapy in Kidney Transplantation: BIRDEM General Hospital Experience

Tufayel Ahmed Chowdhury

BIRDEM Medical Journal, 2016

View PDFchevron_right

Outcome of Cadaveric Renal Transplant Patients Treated for 10 Years with Cyclosporine

Maite Rivera Gorrin

Transplantation, 2001

View PDFchevron_right

The effect of maintenance immunosuppression medication on the change in kidney allograft function

Nathan Johnson

Kidney International, 2004

View PDFchevron_right

Chronic Renal Allograft Damage: Existing Challenges

Daniel Seron

Transplantation, 2011

View PDFchevron_right

Chronic renal allograft rejection: Pathophysiologic considerations

Simone A Joosten

Kidney International, 2005

View PDFchevron_right

Cardiovascular manifestations of allograft dysfunction in renal transplant recipients: a review

amin saburi

Arab journal of nephrology and transplantation, 2014

View PDFchevron_right

Conversion from Cyclosporine to Tacrolimus for Chronic Allograft Nephropathy

Mariano Ferraresso

Transplantation, 2006

View PDFchevron_right

Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion

Kim Solez

American journal of …, 1999

View PDFchevron_right

A Single Institution, Randomized, Prospective Trial of Cyclosporine Versus Azathioprine-Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients

Daniel Canafax

Annals of Surgery, 1985

View PDFchevron_right

Hypertension Effect on Renal Allograft Function and Survival

F. Monteón-ramos

Transplantation, 2004

View PDFchevron_right

A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients

Vivian McAlister, Jean Tchervenkov

Clinical Transplantation, 2005

View PDFchevron_right

Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity

Michael Germain

Transplant International, 1999

View PDFchevron_right

Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era

Christian Seiler

Transplant International, 2006

View PDFchevron_right

Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome

Francesc Moreso

2004

View PDFchevron_right

Identifying and addressing potentially preventable causes of renal allograft loss

Anthony Langone

Kidney International, 2002

View PDFchevron_right

Diagnosis and prevention of chronic kidney allograft loss

El Metwally El Shahawy

The Lancet, 2011

View PDFchevron_right

Renal allograft immunosuppression

Krister Hockerstedt

Transplant International, 1990

View PDFchevron_right

Chronic rejection of rat renal allograft

Eero Taskinen

Transplant International, 1992

View PDFchevron_right

36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil

Dominika Lewandowska

2003

View PDFchevron_right

Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients

james burdick

Kidney International, 1993

View PDFchevron_right

What we CAN do about chronic allograft nephropathy: Role of immunosuppressive modulations

David Goldsmith

Kidney International, 2005

View PDFchevron_right

Patients After Kidney Allograft Failure: Immunologic and Nonimmunologic Considerations

Chrysanthi Skalioti

Transplantation Proceedings, 2015

View PDFchevron_right

Characteristics of Long-Term Live-Donor Renal Allograft Survivors

Ab El

American Journal of Nephrology, 2003

View PDFchevron_right

Peripheral Blood T Lymphocytes Found in Renal Allograft Recipients Treated With Cyclosporine

Monica Liebert

Transplantation, 1983

View PDFchevron_right

An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination

Marcelo Franco

Clinical Transplantation, 2004

View PDFchevron_right

The Management of the Failed Renal Allograft: An Enigma with Potential Consequences

Anthony Langone

Seminars in Dialysis, 2005

View PDFchevron_right